Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH
Yashpal Singh Rawat, Vice President and Facility Director at Fortis Healthcare, shared on LinkedIn:
”Fortis Memorial Research Institute made its positive mark at ASH in USA !
It is a moment of immense pride for all of us at Fortis Memorial Research Institute, Gurugram to witness our institution represented on the global stage at the American Society of Hematology (ASH) 2025 Annual Meeting in Orlando, USA- the most prestigious and influential conference in the field of hematology.
Dr. Rahul Bhargava’s podium oral presentation on “Dissecting India’s Molecular Hematology Landscape: A 1000-patient genomic study” marks not just a scientific achievement but a defining milestone for FMRI.
Taking FMRI’s research from Gurugram to an international platform of this calibre reflects the depth, rigor, and innovation of the work being done here.
This recognition is a testament to the dedication of the entire molecular hematology team-the scientists, clinicians, technologists, and collaborators whose relentless efforts made this study possible.
Your commitment to advancing genomic medicine in India has now been acknowledged at the highest level in global hematology.
Congratulations to Dr. Rahul Bhargava for representing FMRI with excellence, and kudos to every team member who contributed to this landmark achievement.
This is just the beginning, and we look forward to many more such accomplishments that continue to position FMRI as a leader in cutting-edge hematology research.
Proud moment for FMRI.
Proud moment for Fortis Family.”
All from ASH25 featured in Hemostasis Today.
-
Mar 16, 2026, 17:42Mohamed Sherif Salem: Turning 2026 KDIGO Complexity into Bedside Clarity
-
Mar 16, 2026, 17:39Julie Cardoso: What Happens to Venous Valves When a Blood Clot Forms?
-
Mar 16, 2026, 17:38Nasir Jamal: Blood Transfusion Criteria and Hemodialysis Thresholds in ESRD Patients
-
Mar 16, 2026, 17:37Octavio Cosín Sales: Understanding the Influence of Systemic Factors on Chronic Venous Insufficiency
-
Mar 16, 2026, 17:35Shiny K. Kajal: From Simple Calcium Chelation to Full-Blown Red Cell Metabolic Engineering
-
Mar 16, 2026, 17:12Cold-Stored vs Room-Temperature Platelets in Trauma-Induced Coagulopathy – JTH
-
Mar 16, 2026, 17:10Arturo Cesaro: First Meta-Analysis on the Vascular Protective Role of Semaglutide in PAD
-
Mar 16, 2026, 17:01Jeff Sternlicht: The Most Powerful Time to Lower Cholesterol Is Before Anyone Thinks You Need It
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk